top of page

TheraSonic has developed a robotic ultrasound device that is designed to help get medicines past the blood-brain-barrier. It is part of Paris Saclay Cancer Cluster's BOOST accelerator program

Jun 4
1 min read

Co-Founder and CEO Benoit Larrant describes the company's technology and the help it has been receiving from the BOOST program and the broader biotech ecosystem in Paris.

https://vimeo.com/1198405863

Recent Posts

The Zayed Centre for Research into Rare Disease in Children at Great Ormond Street Hospital (GOSH) in London has already been at the cutting edge of new technologies since it opened in 2019

The Zayed Centre for Research into Rare Disease in Children at Great Ormond Street Hospital (GOSH) in London has already been at the cutting edge of new technologies since it opened in 2019

C-Further is a UK based consortium designed to advance new therapies for childhood cancers - researchers and biotech companies should know that it is an option to move programs forward

C-Further is a UK based consortium designed to advance new therapies for childhood cancers - researchers and biotech companies should know that it is an option to move programs forward

Novartis agreed to acquire London based Myricx Bio today for $1.1B up front and up to $400M in milestones. As Myricx's CEO tells us today at the company's HQ, this is all about novel ADC payloads

Novartis agreed to acquire London based Myricx Bio today for $1.1B up front and up to $400M in milestones. As Myricx's CEO tells us today at the company's HQ, this is all about novel ADC payloads

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

10x_Genomics_logo.svg.png

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page